This message was sent to ##Email##
|
|
|
|
| |
 Take advantage of the group registration discount for the Transplant Nursing Symposium: Register 5 Nurses, Get 1 FREE. Use the Symposium as an opportunity to step away from day-to-day concerns and focus on the big picture ideas that will position you to meet the challenges of tomorrow. Register today so you don’t miss the opportunity to hear from dynamic speakers, network with other transplant nurses, earn 19 CE, and more! Save $100 when you register before the 29 August early bird deadline.
 I want to share some of my post symposium thoughts. It seems after every symposium, we say, “that was the best one yet!” And I feel it is true again. I was amazed at the enthusiasm of all the attendees. It was infectious!
Click here to read more.
 Expanded and updated to reflect today's thinking, the ITNS Core Curriculum for Transplant Nurses, second edition offers real-life direction on the science and skills required for every kind of solid organ transplant — from initial evaluation to long-term follow-up. Order your copy today! ITNS members pay only $79.99 USD!
Interested in signing up for a Special Interest Group (SIG) listserv? Learn more and sign up today!
Your shopping makes a difference. Amazon donates to ITNS when you shop Prime Day deals at smile.amazon.com/ch/20-1589538
Thanks for attending the European Transplant Nursing Symposium in Berlin. If you took photos at the symposium you want to share, email them to photocontest@itns.org.
Nurse.org
When you have an emergency, you probably don’t think twice about what you need to do next: you simply head to the hospital, where the trained medical staff can take care of you, right?
But what happens when the hospitals run out of medicine?
READ MORE
News-Medical
Currently, people receiving organ transplants must take drugs to suppress the inflammatory immune response that leads to rejection. Even so, almost all recipients eventually lose their transplant. A new approach, which maintains a population of immune cells that naturally temper immune responses, could greatly enhance people's long-term tolerance for transplants, report researchers at Boston Children's Hospital.
READ MORE
Cancer Therapy Advisor
In a retrospective study of 36 patients, researchers found that allogeneic hematopoietic cell transplantation (allo-HCT) could be a curative treatment in patients with mantle cell lymphoma (MCL).
After 5 years, more than half (54 percent) of patients who underwent allo-HCT for MCL were still alive. Median overall survival (OS) was determined to be 86 months. In addition, progression-free survival (PFS) numbers were promising; the median PFS was 54 months, and after 5 years of observation, PFS was 49 percent.
READ MORE
ScienceDaily
Currently, people receiving organ transplants must take drugs to suppress the inflammatory immune response that leads to rejection. Even so, almost all recipients eventually lose their transplant. A new approach, which maintains a population of immune cells that naturally temper immune responses, known as Tregs, could greatly enhance people's long-term tolerance for transplants.
READ MORE
Healio
A small cohort of patients with sickle cell disease underwent successful hematopoietic stem cell transplantation from non-HLA matched donors, a group previously thought to be incompatible.
Damiano Rondelli, MD, Michael Reese professor of hematology, chief of hematology and oncology, and director of the blood and marrow transplant program at The University of Illinois at Chicago, performed haploidentical HSCT for 10 adults with sickle cell disease.
READ MORE
By Lisa Mulcahy
 Online patient portals and automated visit reminders are standard components of care for most hospitals and practices today. But did you know that there are other simple uses of technology that can raise the quality of care you provide — and contribute to better outcomes across the board for your patients? Research shows that implementing the following technological strategies can lead to excellent results.
READ MORE
News-Medical
Knee pain in active patients over 40 is often difficult to treat but according to researchers presenting their work today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting in San Diego utilizing a special kind of allograft may be a step in the right direction.
"Our findings note that patients older than 40 may benefit from using a fresh osteochondral allograft transplantation to treat focal cartilage defects, a common cause of knee pain in adults," said lead author, Dennis Crawford, MD, PhD from the Oregon Health and Science University in Portland, Oregon.
READ MORE
Nurse.com
I use Twitter frequently to broadcast nursing news, ranging from news about state legislators removing barriers to practice for nurse practitioners to highlights from commencement addresses I give. Oftentimes, I’ll single out nurses for their research findings or acts of compassion.
READ MORE
Healio
Kidney transplant with a kidney infected with hepatitis C virus, followed by treatment for the hepatitis C, was effective and reduced costs compared with transplant with an uninfected kidney after hepatitis C treatment, according to new research published in Annals of Internal Medicine.
“Between 10 percent to 15 percent of U.S. patients receiving dialysis are seropositive for [HCV],” the researchers wrote.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
